Revolution Medicines (NASDAQ:RVMD) Stock Price Expected to Rise, Guggenheim Analyst Says
Revolution Medicines (NASDAQ:RVMD – Get Free Report) had its target price increased by Guggenheim from $82.00 to $87.00 in a research note issued on Tuesday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Guggenheim’s target price would indicate a potential upside of 78.02% from the stock’s previous close. Several other equities research […]
More Stories
Federal Agents Search Rep. Ilhan Omar’s Home: AP Report
By Zachary Stieber Federal agents on Oct. 12 searched the home of Rep. Ilhan Omar (D-Minn.) as part of a...
30-Year Fixed-Rate Mortgage Rate Hits 7.4 percent
By Naveen Athrappully The average weekly rate on a 30-year fixed-rate mortgage hit 7.4 percent, according to a Oct. 8...
US Issues Security Alert to Citizens in Middle East After Houthis Attack Saudi Arabia
By Aldgra Fredly The United States warned American citizens in the Middle East to remain vigilant on Thursday after Yemen’s...
Americans’ Incomes, Net Worth Climbed in Post-Pandemic Years: Federal Reserve
By Andrew Moran Americans’ incomes and net worth rose in the years after the pandemic, the Federal Reserve said in...
Judge Bars Deportation of Illegal Immigrant Shot by ICE in New York
By Aldgra Fredly A federal judge barred the Trump administration from deporting a Dominican immigrant who was shot by a...
‘It’s Time for Ukraine to Get a New President,’ Trump Says
By Timothy Frudd U.S. President Donald Trump suggested on Oct. 10 that Ukraine needs a new leader, one day after...